[{"id":"46f30880-78f6-435b-bfdc-3b82d7b254cf","acronym":"","url":"https://clinicaltrials.gov/study/NCT06581419","created_at":"2025-02-25T20:15:26.057Z","updated_at":"2025-02-25T20:15:26.057Z","phase":"Phase 1/2","brief_title":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT06581419","lead_sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IAP0971"],"overall_status":"Recruiting","enrollment":" Enrollment 78","initiation":"Initiation: 12/31/2024","start_date":" 12/31/2024","primary_txt":" Primary completion: 08/01/2029","primary_completion_date":" 08/01/2029","study_txt":" Completion: 08/01/2029","study_completion_date":" 08/01/2029","last_update_posted":"2025-01-15"},{"id":"ac8040d4-cfc1-4fe3-9ea2-d1cab77d649a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05396391","created_at":"2022-05-31T12:54:38.615Z","updated_at":"2024-07-02T16:35:42.451Z","phase":"Phase 1/2","brief_title":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT05396391","lead_sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IAP0971"],"overall_status":"Recruiting","enrollment":" Enrollment 140","initiation":"Initiation: 06/22/2022","start_date":" 06/22/2022","primary_txt":" Primary completion: 05/30/2024","primary_completion_date":" 05/30/2024","study_txt":" Completion: 11/30/2024","study_completion_date":" 11/30/2024","last_update_posted":"2023-07-20"}]